December 4th 2024
Your daily dose of the clinical news you may have missed.
December 2nd 2024
November 27th 2024
A woman in her early 50s presents with 6 hours of right sided pleuritic chest pain. What do the history and ECG suggest? What's yoru Dx?
November 26th 2024
The patient shows no signs of trauma but is a poor historian so no further details are available. Do her vitals or ECG provide any clues to a Dx?
November 25th 2024
Study: Surprising Number of Postpartum Hypertension Cases Occurred More than 6 Weeks After Birth
Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.
Bariatric Surgery Halves Adverse CVD Events in Patients with NAFLD, Severe Obesity
Bariatric surgery reduced by half the risk of CV events including myocardial infarction, heart failure, and stroke compared to nonsurgical care.
How to Build an Obesity Phenotype Step-by-Step, with Andres Acosta, MD, PhD
Obesity phenotyping uses a battery of validated tests and procedures to determine the root cause of a patient's disease and then match treatment accordingly.
Andres Acosta, MD, Discusses the Challenge of Heterogeneity in Response to Obesity Treatment
Acosta, a pioneer in the phenotyping of obesity, says one-third of patients don't respond to treatment and he knows why.
Daily Dose: Remote Hypertension and Lipid Program
Your daily dose of clinical news you may have missed.
Baxdrostat in Phase 2 Clinical Trial Proves Effective, Safe in Treatment-resistant Hypertension
Baxdrostat shows potential to represent the first new class of antihypertensive agents approved since 2017.
Fully Remote Intervention for Hypertension, Lipids Proves Feasible, Successful in Large, Diverse Health Care Network
The Mass General Brigham clinical intervention and study included 10 000 participants and resulted in significant reductions in SBP/DBP and LDL-C.
Daily Dose: Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women
Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.
Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
Early Months of COVID-19 Associated with Worsening BP Outcomes in Adults with Hypertension, New Study Finds
Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.
Physicians Should Get Patients to Move More to Help with Cardiometabolic Health, Says One Expert
To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.
Drop in Vitamin D Implies Increased Cardiovascular Risk in T2D, According to New Research
CMHC 2022: A decrease in vitamin D levels is associated with increased cardiovascular risk in patients with type 2 diabetes, according to new study.
The Daily Dose: More Readmissions in Women than Men after Myocardial Infarction
Your daily dose of clinical news from Patient Care Online.
More Readmissions in Women than Men after Acute Myocardial Infarction, New Study Finds
Findings underscore the need for ongoing efforts to improve prevention strategies, as CVD risk factors in younger women continue to rise, according to authors.
The Daily Dose: CVD Risk Factors Linked to COVID-19 Death
4 New Drugs Approved for Primary Care: Q3 2022
Novel NMDA receptor antagonist approved for the treatment of major depressive disorder, first topical PDE4i approved for plaque psoriasis, and more.
Food Insecurity Rose among US Adults with Cardiovascular Disease, According to National Study
The rate of food insecurity among persons with CVD nearly doubled over 20 years, according to new research.
Migraine with Aura Characterized as Independent Risk Factor for Atrial Fibrillation
Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.
Intervention Reduces Aspirin Use in Patients with AF, VTE Taking Warfarin, Improves Outcomes
An aspirin deprescribing intervention at anticoagulation clinics led to a 50% reduction in use among patients with AF, VTE prescribed warfarin.
Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study Finds
AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.
Abelacimab Receives Fast Track Designation from FDA for Prevention of Stroke, Systemic Embolism in Patients with Atrial Fibrillation
Abelacimab is a dual-acting, fully human monoclonal antibody that selectively targets both factor XI and factor XIa with high affinity.
DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation Study
AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.
Education on Use of ABPM Data Needed in Primary Care to Avoid Misdiagnosis of Hypertension
AHA Hypertension 2022. Half of patients with newly elevated BP had white coat HTN yet some were diagnosed with HTN at next primary care visit, new study finds.
COVID-19 mRNA Vaccines Found Safe in Patients with Heart Failure in Real-world Study
ESC 2022: SARS-CoV-2 mRNA vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism, or myocarditis in a large Danish real-world study.
Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.
Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.
Early Rhythm Control May Not be as Effective in Adults with Newly Diagnosed Atrial Fibrillation
Early rhythm control reduced CV complications regardless of AF pattern but for patients with a first AF diagnosis, risks for hospitalization and ACS were higher after early rhythm therapy.
7 New Drugs Approved for Primary Care: Q2 2022
From type 2 diabetes to chronic yeast infection, we have picked the top 7 FDA-approved drugs every primary care physician should know about from the second quarter.